Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. marsi

MARSI SIGNED

Disruptive technologies for effectively rehabilitating chronic ambulatory disability

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MARSI project word cloud

Explore the words cloud of the MARSI project. It provides you a very rough idea of what is the project "MARSI" about.

correspond    health    treatments    sme    week    acquiring    difficulty    physical    everyday    company    diseases    roughly    impedes    device    portfolio    barrier    neurological    injury    joining    mobility    spina    people    million    complications    industrial    avoiding    models    jobs    sessions    worlwide    share    elders    disorders    commercialized    life    36m    time    renting    synchronized    dementia    disabled    cord    spinal    rehabilitation    escribano    musculoskeletal    therapeutic    physically    weakness    minimal    nervous    frame    strength    market    quadriplegia    cerebral    neuromuscular    ares    turnover    marsi    enlarge    overcome    muscles    lifestyle    functional    remaining    active    expensive    safely    effortlessly    covers    speed    lower    palsy    function    certification    orthoses    14    quality    min    paraplegia    medicines    stroke    bionics    restore    powered    progressive    autonomy    daily    alliance    bifida    programs    2023    minimize    joints    15    industrialization    critical    81    walking    muscle    limited    house    motor    disorder    showing    patients    ambulatory    expectancy    disability    psychosocial    sum    losing    walk   

Project "MARSI" data sheet

The following table provides information about the project.

Coordinator		 MARSI BIONICS SL 

Organization address
address: CALLE RUE DEL PERCEBE 30
city: RIVAS VACIAMADRID
postcode: 28521
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Spain [ES]
 Project website http://www.marsibionics.com/
 Total cost 2˙499˙150 €
 EC max contribution 1˙640˙730 € (66%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2020-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MARSI BIONICS SL ES (RIVAS VACIAMADRID) coordinator 1˙640˙730.00

Map

 Project objective

Worlwide, about 60 million people have some kind of difficulty in walking, which is related to some neurological disorder (stroke, dementia, neuromuscular diseases, etc). Roughly 40 million of affected correspond to elders and the % is higher in Europe. The remaining is the sum of physically disabled by cerebral palsy (14 million), neuromuscular diseases (4 million), spinal cord injury (paraplegia and quadriplegia, 3 million) and spina bifida (3 million). Neurological disorders affect the lower motor of the nervous system and share the progressive muscle weakness, which lead to several walk disability, loss of autonomy and psychosocial consequences. Most therapeutic treatments are limited to medicines and musculoskeletal rehabilitation programs, which are very expensive and limited to 15-30 min/week rehabilitation sessions. Active lifestyle is the most effective measure to restore the physical conditions. But the loss of muscle strength impedes the ambulatory function. The need is for a device allowing them walking effortlessly and safely in the everyday life activities. Based on our ARES technology, -the minimal functional unit providing synchronized joints-muscles mobility- Marsi Bionics has developed powered orthoses for in-house rehabilitation of patients affected by muscle weakness disorders, showing a product portfolio that covers the needs of a wide range of Neurological Disorders. Marsi products will be commercialized under renting models allowing patients acquiring it for daily use. This technology will improve these patients life quality and enlarge life expectancy by avoiding critical health complications of losing walking ability. Marsi is strengthened by joining with a leading company in the current industrial market, ESCRIBANO. This alliance in the frame of SME Phase 2 will speed up industrialization, overcome the certification barrier and minimize the time to market. As a result, we expect to reach above 36M€ turnover in 2023 and 81 generated jobs.

 Deliverables

List of deliverables.
Dissemination and Communication continuous monitoring (actions, results, congresses, materials and KPI. Documents, reports 2020-03-04 09:47:52

Take a look to the deliverables list in detail:  detailed list of MARSI deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MARSI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MARSI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More